Detalles de la búsqueda
1.
Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors.
Invest New Drugs
; 30(2): 695-701, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20857170
2.
Cancer cell lines as genetic models of their parent histology: analyses based on array comparative genomic hybridization.
Cancer Res
; 67(8): 3594-600, 2007 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17440070
3.
High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization.
Breast Cancer Res
; 7(6): R1186-98, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16457699
4.
Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer.
Clin Cancer Res
; 16(6): 1938-49, 2010 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20215545
5.
Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapy.
J Clin Oncol
; 26(7): 1066-72, 2008 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18212337
Resultados
1 -
5
de 5
1
Próxima >
>>